Search results
Nintendo Just Quietly Added A Breezy, Life-Giving RPG
Inverse· 9 hours agoBiomutant is out May 14 on Switch after a much delayed port release date. The open-world action...
AI aids analysis of lifetime environmental exposures
Medical Xpress· 1 day agoMost human diseases are fueled by both genetic and environmental factors. Untangling these external influences and how they intersect with our genes...
This Mother's Day - A NJ Mother & Daughter Are Gra | Newswise
Newswise· 5 days agoMerlise Diaz, 48, and her daughter, Leslie Grullon, 32, were diagnosed with triple negative breast...
Team develops efficient host-vector system for a model archaeon by solving CRISPR-based host-plasmid...
Phys.org· 4 days agoA research group has constructed versatile genetic tools for Saccharolobus islandicus REY15A, one of the very few archaeal models for archaea biology and CRISPR biology research.
Vlad appoints new right-hand man ‘Prof Doomsday’ who says West should be nuked
The US Sun· 5 days agoTYRANT Vladimir Putin has recruited a new despicable pal to his government dubbed "Professor...
This Is the Average Age for Gray Hair to Begin Showing
InStyle· 6 days ago“Going gray is a normal part of the aging process,” says Nexxus hair-care partner and celebrity...
Exploring the biological basis for resilience
Medical Xpress· 1 day agoProfessor for Child and Adolescent Psychiatry, studies psychological resilience, which helps people withstand stress and trauma without lasting damage to their mental health. Resilience is a ...
KORU Medical enters Phase III trial for rare disease therapy By Investing.com
Investing.com· 5 hours agoKORU Medical Systems, Inc. (NASDAQ: KRMD), a company specializing in large volume subcutaneous...
Star Trek: Discovery goes out as it came in: robbing better shows of their mystique
VG247· 3 days agoCards on the table: I’ll watch anything if it has Star Trek in the title. It was a bit pants – an...
Earnings call: Aadi Bioscience reports on Q1 2024 and trial updates By Investing.com
Investing.com· 5 days agoThe company's flagship PRECISION1 trial for nab-sirolimus is now fully enrolled, targeting a...